CIG Q1 2026 Earnings EPS Beat Fails to Ignite Stock as Revenue Details Remain Absent Ernexa Therapeutics ERNA Q3 2023 Earnings Net loss of 103 per share highlights ongoing clinical investment stock declines 377 ALRS Q1 2026 Earnings EPS Beat by 4838 but Stock Declines 057 TRS Q1 2026 Earnings EPS Beats Estimates by 2539 Toro Corp Q4 2025 Earnings Modest Profitability as Stock Slips 226 SO Q1 2026 Earnings EPS Surprises to the Upside Stock Edges Higher